Skip to content

Serum proteomic analysis of cyclopophenol-induced muscle spasticity

Serum proteomic analysis of cyclopophenol-induced muscle spasticity

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091774
Enrollment
Unknown
Registered
2024-11-04
Start date
2024-11-04
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colitis

Interventions

Control group:N/A
Muscle spasm group:N/A

Sponsors

Wuxi Huishan District, People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) All subjects voluntarily signed the informed consent for this study (2) age greater than or equal to 20 years old, less than 65 years old (3) voluntarily underwent painless colonoscopy (4) No history of fat allergy (5) no muscle-nerve disease

Exclusion criteria

Exclusion criteria: (1) History of allergy to cyclopropofol (2) history of mental illness and drug abuse (3) Severe cardiopulmonary diseases (heart failure, II degree atrioventricular block, severe COPD, etc.) (4) History of hyperthyroidism (5) surgical history of cardiopulmonary disease (6) history of craniocerebral surgery (7) Patients who could not be enrolled for any reason considered by the investigators

Design outcomes

Primary

MeasureTime frame
serum protein;

Secondary

MeasureTime frame
Muscle spasm time;Dosage of Cyclophenol;Colonoscopy operation time (min);

Countries

China

Contacts

Public ContactYu Zhiyang

Wuxi Huishan District, People's Hospital

yuzhiyang2020@sohu.com+86 510 8331 8200

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026